Please use this identifier to cite or link to this item:
https://hdl.handle.net/1959.11/27493
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kanwar, Abhay Vir Singh | en |
dc.contributor.author | Rahim, Mia Mahmudur | en |
dc.date.accessioned | 2019-08-30T00:37:46Z | - |
dc.date.available | 2019-08-30T00:37:46Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | Journal of Law and Medicine, 26(4), p. 750-763 | en |
dc.identifier.issn | 1320-159X | en |
dc.identifier.uri | https://hdl.handle.net/1959.11/27493 | - |
dc.description.abstract | Although the pharmaceutical industry is a multi-billion-dollar business, it fails to save the lives of millions. Astronomical drug prices are not just an economic problem that can be settled through clever marketing strategies but a significant ethical issue. This article delves into the ethical health care paradigm, which can supplant the present economistic paradigm. Grounded in the ethical-philosophical argument for recognising an individual's right to be healthy, it asserts the practical proposal of cost rationalisation and universal availability of essential and lifesaving drugs. This is achievable by supporting research and development funding for drug innovation by the business establishment, and as such falls within the scope of corporate social responsibility. | en |
dc.language | en | en |
dc.publisher | Lawbook Co | en |
dc.relation.ispartof | Journal of Law and Medicine | en |
dc.title | Social Responsibilities of the Global Pharmaceutical Companies: Towards an Ethical Health Care Paradigm | en |
dc.type | Journal Article | en |
local.contributor.firstname | Abhay Vir Singh | en |
local.contributor.firstname | Mia Mahmudur | en |
local.subject.for2008 | 180119 Law and Society | en |
local.subject.for2008 | 220105 Legal Ethics | en |
local.subject.seo2008 | 910401 Industrial Relations | en |
local.subject.seo2008 | 949999 Law, Politics and Community Services not elsewhere classified | en |
local.profile.school | School of Law | en |
local.profile.email | mrahim@une.edu.au | en |
local.output.category | C1 | en |
local.record.place | au | en |
local.record.institution | University of New England | en |
local.publisher.place | Australia | en |
local.format.startpage | 750 | en |
local.format.endpage | 763 | en |
local.peerreviewed | Yes | en |
local.identifier.volume | 26 | en |
local.identifier.issue | 4 | en |
local.title.subtitle | Towards an Ethical Health Care Paradigm | en |
local.contributor.lastname | Kanwar | en |
local.contributor.lastname | Rahim | en |
dc.identifier.staff | une-id:mrahim | en |
local.profile.orcid | 0000-0003-0637-8445 | en |
local.profile.role | author | en |
local.profile.role | author | en |
local.identifier.unepublicationid | une:1959.11/27493 | en |
dc.identifier.academiclevel | Academic | en |
dc.identifier.academiclevel | Academic | en |
local.title.maintitle | Social Responsibilities of the Global Pharmaceutical Companies | en |
local.output.categorydescription | C1 Refereed Article in a Scholarly Journal | en |
local.relation.url | http://sites.thomsonreuters.com.au/journals/2019/08/09/journal-of-law-and-medicine-update-vol-26-pt-4/ | en |
local.search.author | Kanwar, Abhay Vir Singh | en |
local.search.author | Rahim, Mia Mahmudur | en |
local.uneassociation | Unknown | en |
local.year.published | 2019 | en |
local.fileurl.closedpublished | https://rune.une.edu.au/web/retrieve/f961e482-3a90-4585-8322-4bb1952672d8 | en |
local.subject.for2020 | 480405 Law and society and socio-legal research | en |
local.subject.for2020 | 500105 Legal ethics | en |
local.subject.seo2020 | 150301 Industrial relations | en |
Appears in Collections: | Journal Article School of Law |
Files in This Item:
File | Description | Size | Format |
---|
Page view(s)
2,232
checked on Aug 25, 2024
Download(s)
8
checked on Aug 25, 2024
Items in Research UNE are protected by copyright, with all rights reserved, unless otherwise indicated.